SEC Form 4 · accession 0001209191-19-016490
MAGELLAN HEALTH INC · MGLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mostafa Kamal
Officer — CEO, Magellan Rx Management
Period of report
Mar 3, 2019
Accepted (ET)
Mar 5, 2019 · 4:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019411
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Common Stock, $0.01 par valueF2 | Mar 3, 2019 | M | 3,996 | $0.00 | A | 4,509 | D | |
| Ordinary Common Stock, $0.01 par valueF4 | Mar 3, 2019 | F | 2,011 | $68.33 | D | 2,498 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2 | $0.00 | Mar 3, 2019 | M | 3,996 | D | Mar 3, 2019 | — | Common Stock | 3,996 | 0 | D |
Explanation of responses
- F1This transaction was effectuated by the vesting of the Performance Stock Units granted on March 3, 2016. The number of shares that vested were based upon the achievement of total shareholder return over a 3 year period beginning 2016 and ending with 2019.
- F2Not applicable.
- F3Represents the portion of shares withheld by the Company in order to pay taxes.
- F4Closing price on NASDAQ on March 4, 2019.